
Entrepreneurs often pitch new products by comparing them to familiar ones, describing a device as similar to an existing approved item. This approach helps attract investors and entice consumers, but do these comparisons actually help companies win regulatory approval? Harvard Business School faculty member Tiona Zuzul explored that question in an article published in the Strategic Management Journal in February.
Researchers analyzed letters from medical device companies to the U.S. Food and Drug Administration, investigating how firms use required comparisons to past products strategically. They discovered that effective comparisons can significantly reduce approval times, sometimes by weeks or months. This is because such comparisons help overburdened regulators better grasp the new product’s features.
Pahnke observes, “Anytime you want to join a club of any kind, it’s helpful to look like you belong in that club already.” The goal isn’t to deceive regulators but to provide clarity.
How Approval Times Vary
Getting over the hurdle of FDA approval is critical in the medical device industry, where firms often strive to maintain strict timetables as they compete to launch products faster than rival companies. In an analysis of 239 new firms’ clearances between 2001 and 2019, the researchers found an enormous range in the amount of time approvals take, anywhere from seven days on the low end to 800 days—more than two years—on the high end. In more than 50 interviews with founders and regulators, the research team discovered that the time difference can make or break a product.
Read Also: How Voltage Settings Influence X-Ray Imaging Capabilities
For first-time products, citing multiple comparable items didn’t speed up approval. In fact, applications with just one comparison were approved fastest, while each additional comparison increased approval time by 8%. Applications that compared a new product to an approved device in the same product category had an 80% chance of approval within 200 days. Meanwhile, applications citing an item from a different product category had only a 20% chance of approval in that timeframe. A focused comparison makes regulators’ jobs easier. Interviews with regulators revealed that a single, clear comparison to a similar product reduced the cognitive load of evaluating a new product’s safety and effectiveness.
The Power of a Star Product
Citing a category’s “star” product helps even more. The researchers also pored through the letters to see what products were cited most within each product category. They found that firms that cited one of these “star” products in their first application were cleared faster, with about a 65% higher likelihood of approval at any given point in time.
Leveraging Your Own Track Record
When seeking approval for a second product, firms reduced approval times more substantially by comparing it to their own previously approved product than to a star product from another company, even if their own earlier product was not widely known. “If you are telling the regulator in your application that your second spinal screw is the same as your first spinal screw, it doesn’t really matter if the regulator knows what your first spinal screw is like,” Zuzul says. “They’re going to believe you.”
While the researchers studied medical devices, they believe the results could be applied more broadly to industries that rely on regulatory approval for success. Based on the findings, the research team makes recommendations about positioning new products, including facilitating a straightforward comparison and making the case using a single similar product. By following these strategies, companies can potentially reduce approval times and increase their chances of success. The research provides valuable insights for startups and established companies alike, highlighting the importance of effective comparisons in the regulatory approval process.
